RMC-9805 / DARAXON portfolio
Zoldonrasib API
RMC-9805 active pharmaceutical ingredient for KRAS G12D research and pharmaceutical development. U.S. FDA DMF 44304.
Product overview
Active pharmaceutical ingredient
Zoldonrasib, development code RMC-9805, is described by its developer as a RAS(ON) G12D-selective inhibitor. Daraxon offers the API for professional development programs, with specifications and documentation scoped to the intended use.
Revolution Medicines · Zoldonrasib / RMC-9805↗- Product
- Zoldonrasib API
- Development code
- RMC-9805
- Material format
- Active pharmaceutical ingredient
- Research context
- RAS(ON) G12D-selective inhibitor
- U.S. FDA DMF
- 44304 · Type II
- Submission date
- 2026-06-08
- Status in the 2026 Q3 list
- A — Active
- FDA-listed holder
- SHANGHAI DA'AN XIN BIOMEDICAL CO LTD
Traceable filing record
FDA DMF 44304
Filing details checked against the FDA 2026 Q3 DMF list and reflect that quarterly snapshot. A DMF filing is not FDA drug approval.
Technical documentation
Define the package for your program.
- Batch Certificate of Analysis and agreed product specification
- Identity and chromatographic records within the agreed documentation package
- DMF reference and Letter of Authorization requirements
Product inquiry
Talk to the Daraxon team.
Include intended use, quantity, destination and documentation requirements.